written by reader A +229% biotech

by kmoffitt6 | June 10, 2014 1:15 am

So many biotechs, so little time. A biotech, IDIX, gained 229% today on news that Merck will be buying this company that is developing a hepatitis C drug. It always amazes me when I see this happen to a stock that I haven’t seen teased! Hindsight highlights the good, bad, and envious:-)

Source URL: https://www.stockgumshoe.com/2014/06/microblog-a-229-biotech/


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.